Metformin Flamingo Pharma Uk

Metformin, the active ingredient in Metformin Flamingo Pharma Uk, is a biguanide presented as an oral dosage form for oral administration. It is indicated for the management of type 2 diabetes mellitus in adult patients, helping to control elevated blood glucose levels.

GNH USA supplies Metformin Flamingo Pharma Uk as a licensed, GDP‑compliant product sourced from the European Union, providing reliable pharmaceutical supply to hospitals, pharmacies and clinics worldwide through established international distribution channels and meeting stringent quality standards for patient care.

Metformin is a biguanide antidiabetic that improves glycemic control in type 2 diabetes.

- Type 2 diabetes mellitus (adults): lowers fasting and post‑prandial glucose levels - Type 2 diabetes mellitus (adolescents): improves glycemic control under specialist supervision

Metformin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset - Diarrhea: frequent loose stools, especially during dose titration - Abdominal discomfort: cramping or bloating - Metallic taste: transient alteration of taste perception

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis - Severe hypoglycemia: usually when combined with insulin or sulfonylureas - Hepatic dysfunction: marked liver enzyme elevations - Allergic skin reactions: rash, urticaria, or angioedema - Vitamin B12 deficiency: may develop with long‑term therapy

Metformin requires careful patient assessment and monitoring.

- Renal function: assess eGFR before initiating and periodically monitor - Lactic acidosis risk: avoid in patients with severe hepatic impairment or hypoxia - Alcohol consumption: limit as it may increase lactic acidosis risk - Pregnancy and lactation: use only if benefits outweigh risks - Drug interactions: review concomitant medications for potential interactions - Store at ambient temperature: keep below 25°C in the original container, protect from moisture

Metformin may interact with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate renal dysfunction - Cimetidine: can increase metformin plasma levels - Nitrates: risk of severe hypotension when combined

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms - Diuretics: may affect renal clearance of metformin - ACE inhibitors: monitor renal function and electrolytes